The company invests in newly founded or early-stage platform companies globally, with a focus on bringing first-in-class drug candidates to patients using novel science and innovative technologies. Droia has a team of seasoned scientists, entrepreneurs, and investment professionals who work to build great companies that save patient lives. They invest in early financing rounds and incubate new companies, actively supporting young drug development companies to achieve clinical proof of concept with their lead programs. With an in-house team of experts and drug development professionals, Droia follows the portfolio companies closely and provides hands-on support to accelerate their progress. Operating from Luxembourg and Belgium, Droia is dedicated to making an impact and saving patient lives.